BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23527639)

  • 1. 17β-Estradiol suppresses MHC class I chain-related B gene expression via an intact GC box.
    Sroijak N; Ponglikitmongkol M
    Biochem Cell Biol; 2013 Apr; 91(2):102-8. PubMed ID: 23527639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of MICA and MICB: a novel polymorphism in MICB promoter alters transcriptional regulation by Sp1.
    Rodríguez-Rodero S; González S; Rodrigo L; Fernández-Morera JL; Martínez-Borra J; López-Vázquez A; López-Larrea C
    Eur J Immunol; 2007 Jul; 37(7):1938-53. PubMed ID: 17557375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells.
    Kato N; Tanaka J; Sugita J; Toubai T; Miura Y; Ibata M; Syono Y; Ota S; Kondo T; Asaka M; Imamura M
    Leukemia; 2007 Oct; 21(10):2103-8. PubMed ID: 17625602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity and characterization of polymorphic 5' promoter haplotypes of MICA and MICB genes.
    Cox ST; Madrigal JA; Saudemont A
    Tissue Antigens; 2014 Sep; 84(3):293-303. PubMed ID: 24962621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Battle of the midgets: innate microRNA networking.
    Elias S; Mandelboim O
    RNA Biol; 2012 Jun; 9(6):792-8. PubMed ID: 22617882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.
    Schilling D; Kühnel A; Tetzlaff F; Konrad S; Multhoff G
    Cancer Immunol Immunother; 2015 May; 64(5):599-608. PubMed ID: 25854583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
    Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
    Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma.
    Raffaghello L; Prigione I; Airoldi I; Camoriano M; Levreri I; Gambini C; Pende D; Steinle A; Ferrone S; Pistoia V
    Neoplasia; 2004; 6(5):558-68. PubMed ID: 15548365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.
    Okita R; Mougiakakos D; Ando T; Mao Y; Sarhan D; Wennerberg E; Seliger B; Lundqvist A; Mimura K; Kiessling R
    J Immunol; 2012 Mar; 188(5):2136-45. PubMed ID: 22301547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
    Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S
    Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis.
    Zhang C; Wang Y; Zhou Z; Zhang J; Tian Z
    Cancer Immunol Immunother; 2009 Aug; 58(8):1275-85. PubMed ID: 19139882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the human 5-HT7 receptor gene and characterization of its promoter region.
    Laenen K; Haegeman G; Vanhoenacker P
    Gene; 2007 Apr; 391(1-2):252-63. PubMed ID: 17321075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein.
    Wu J; Chalupny NJ; Manley TJ; Riddell SR; Cosman D; Spies T
    J Immunol; 2003 Apr; 170(8):4196-200. PubMed ID: 12682252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2.
    Uhlenbrock F; van Andel E; Andresen L; Skov S
    Mol Immunol; 2015 Aug; 66(2):418-27. PubMed ID: 25983110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SP1 and SP3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium.
    Cheng YH; Imir A; Suzuki T; Fenkci V; Yilmaz B; Sasano H; Bulun SE
    Biol Reprod; 2006 Oct; 75(4):605-14. PubMed ID: 16807381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate.
    Chávez-Blanco A; De la Cruz-Hernández E; Domínguez GI; Rodríguez-Cortez O; Alatorre B; Pérez-Cárdenas E; Chacón-Salinas R; Trejo-Becerril C; Taja-Chayeb L; Trujillo JE; Contreras-Paredes A; Dueñas-González A
    Int J Oncol; 2011 Dec; 39(6):1491-9. PubMed ID: 21805029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
    Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
    J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17.
    Ren J; Nie Y; Lv M; Shen S; Tang R; Xu Y; Hou Y; Zhao S; Wang T
    Cell Mol Immunol; 2015 Nov; 12(6):768-76. PubMed ID: 25363527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microRNAs in the control of innate immune response in cancer.
    Jasinski-Bergner S; Mandelboim O; Seliger B
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.